United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2022_register executive 2022-01-13 article Proposed Rules D09002ee1c7aa4562 D09002ee1c7aa4698 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing on scientific data and information related to the residue of carcinogenic concern for the new animal drug carbadox, a carcinogenic new animal drug used in swine feed. 87 FR 2093 https://www.govinfo.gov/app/details/FR-2022-01-13/2022-00475 2022-00475 fr13ja22-20 4164-01-P Docket No. FDA-2021-N-1326 https://www.govinfo.gov/app/details/FR-2022-01-13/2022-00475 https://www.govinfo.gov/content/pkg/FR-2022-01-13/html/2022-00475.htm https://www.govinfo.gov/content/pkg/FR-2022-01-13/pdf/2022-00475.pdf 3 p. 2093 2095 87 FR 2093 Title 21 Part 15 21 CFR Part 15 Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox; Public Hearing; Request for Comments; Federal Register Vol. 87, Issue PRORULE 2022-00475 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 2022-02-18 2022-03-10 Docket No. FDA-2021-N-1326 4164-01-P 2022-00475 Notice of public hearing; request for comments.

The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing on scientific data and information related to the residue of carcinogenic concern for the new animal drug carbadox, a carcinogenic new animal drug used in swine feed.

The public hearing will be held virtually on March 10, 2022, from 1 p.m. to 5 p.m., Eastern Time. Persons interested in attending this public hearing must register no later than 11:59 p.m. Eastern Time on March 9, 2022. Persons interested in making oral presentations and comments at the public hearing must submit requests by February 18, 2022. Submit either electronic or written comments on this hearing by April 11, 2022. See the SUPPLEMENTARY INFORMATION section for registration dates and information. Kelly Covington, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, CarbadoxPublicHearing2022@fda.hhs.gov, 240-402- 5661. Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox, CarbadoxPublicHearing2022@fda.hhs.gov https://fda.zoomgov.com/j/1600135012?pwd=MFdjMW9FRXg4RGllc3FHWVhkWVAyZz09 https://www.fda.gov/about-fda/center-veterinary-medicine/cvm-foia-electronic-reading-room https://www.fda.gov/animal-veterinary/workshops-conferences-meetings/part-15-public-hearing-scientific-data-and-information-related-residue-carcinogenic-concern-new https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf https://www.regulations.gov Vol. 87, no. 9 Office of the Federal Register, National Archives and Records Administration 2022-01-13 continuing daily deposited born digital 291 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2022-01-13 P0b002ee1b2f698ed 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr13ja22 https://www.govinfo.gov/app/details/FR-2022-01-13 https://www.govinfo.gov/content/pkg/FR-2022-01-13/pdf/FR-2022-01-13.pdf https://www.govinfo.gov/content/pkg/FR-2022-01-13/xml/FR-2022-01-13.xml fdlp 2027 2307 DGPO 2022-01-13 2024-05-29 FR-2022-01-13 machine generated eng FR FR-2022-01-13 87 9